Certain Restricted Stock Units of Augmedix, Inc. are subject to a Lock-Up Agreement Ending on 14-FEB-2024.
February 13, 2024
Share
Certain Restricted Stock Units of Augmedix, Inc. are subject to a Lock-Up Agreement Ending on 14-FEB-2024. These Restricted Stock Units will be under lockup for 91 days starting from 15-NOV-2023 to 14-FEB-2024.
Details:
Directors and executive officers are subject to lock-up agreements that prohibit the company and them from offering, selling, contracting to sell, granting any option or contract to purchase, purchasing any option or contract to sell, granting any option, right or warrant to purchase, lending or otherwise transferring or disposing of any shares of common stock or any securities convertible into or exercisable or exchangeable for shares of common stock or other capital stock for a period of at least 90 days (and at least nine months for certain major shareholders) following the date of this prospectus supplement without the prior written consent of Evercore Group L.L.C. and William Blair & Company, L.L.C., in each case subject to customary exceptions.
Augmedix, Inc. helps clinicians and patients form a human connection at the point of care. The Company uses its proprietary Notebuilder Platform to automate the note creation process, aided by its trained MDSs. It also provides data services associated with these products, which include aggregated structured data and metadata associated with medical notes. Its products include Augmedix Live, Augmedix Notes, Augmedix Prep and Augmedix Go. Augmedix Live provides synchronous medical note documentation and point of care support. Augmedix Notes provides asynchronous medical documentation based upon previously recorded visit. Prep provides chart preparation delivered prior to the patient visit. Prep transfers patient demographics, past medical history, medication changes and other key data points from the patientâs health to the current visit note. Clinicians access its products and service through mobile devices, managed by it or their health enterprise.
AUGMEDIX, INC. 
